New research has revealed the potential of engineered proteins to more precisely deliver drugs within the body.

Omnicell has developed automated systems that can organize medicine trays, help nurses find medication quicker and help ...

The common hospital-acquired, antibiotic-resistant bacterial infection is known to cause infections in the blood, lungs and urinary tract after surgery. While symptoms can vary depending on the site ...

The investment strengthens Maryland’s position as a biotech hub and reflects AstraZeneca’s commitment to local job creation ...

Indian biopharma firm Biocon's profit more than doubled in the fourth quarter, led by strong demand for its generics and biosimilar drugs in its key U.S. and European markets.

Cardiovascular disease remains a leading cause of morbidity and mortality worldwide, with atherosclerotic cardiovascular ...

Researchers in the United Kingdom identified an enzyme, which they called Pap1, in a strain of Pseudomonas aeruginosa ...

Bacterial resistance negates the effect of antibiotics in the treatment of infection. Using mouse models, researchers now show that if antibiotics are administered with an enzyme called endolysin, the ...

AstraZeneca (AZN) and Daiichi Sankyo (DSNKY) announce that Enhertu hit the main goal in a Phase 3 trial for early-stage ...

IO Biotech, a clinical-stage biopharmaceutical company focused on developing immune-modulatory cancer vaccines, announced that its co-founder Dr. Mads Hald Andersen chaired an educational session ...

It's odd that Summit is plunging so much ... Investors in these stocks should be very aware that early-stage biotech stocks have huge upside but also bust potential, and to invest within your ...

A biotech firm based in Milton Park, Oxfordshire, has received a major boost after its T-cell therapy was awarded Breakthrough Therapy Designation by the US Food and Drug Administration, which will ...